Thorne, the leader in science-backed health and wellness solutions, today announced that it has entered into a definitive agreement to be acquired by The Procter & Gamble Company (NYSE:PG).

The transaction is expected to close later this year, subject to customary closing conditions and regulatory approvals. P&G will acquire Thorne from L Catterton's Flagship Fund. Perella Weinberg served as the lead financial advisor to Thorne.